Can tweets be used to detect problems early with scientific papers? A case study of three retracted COVID-19/SARS-CoV-2 papers

被引:1
|
作者
Robin Haunschild
Lutz Bornmann
机构
[1] Max Planck Institute for Solid State Research,Science Policy and Strategy Department, Max Planck Society
[2] Administrative Headquarters,undefined
来源
Scientometrics | 2021年 / 126卷
关键词
Twitter; Scientometrics; Altmetrics; COVID-19; SARS-CoV-2; Retracted papers;
D O I
暂无
中图分类号
学科分类号
摘要
Methodological mistakes, data errors, and scientific misconduct are considered prevalent problems in science that are often difficult to detect. In this study, we explore the potential of using data from Twitter for discovering problems with publications. In this case study, we analyzed tweet texts of three retracted publications about COVID-19 (Coronavirus disease 2019)/SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and their retraction notices. We did not find early warning signs in tweet texts regarding one publication, but we did find tweets that casted doubt on the validity of the two other publications shortly after their publication date. An extension of our current work might lead to an early warning system that makes the scientific community aware of problems with certain publications. Other sources, such as blogs or post-publication peer-review sites, could be included in such an early warning system. The methodology proposed in this case study should be validated using larger publication sets that also include a control group, i.e., publications that were not retracted.
引用
收藏
页码:5181 / 5199
页数:18
相关论文
共 50 条
  • [31] Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic
    Sheervalilou, Roghayeh
    Shirvaliloo, Milad
    Sargazi, Saman
    Shirvalilou, Sakine
    Shahraki, Omolbanin
    Pilehvar-Soltanahmadi, Younes
    Sarhadi, Alireza
    Nazarlou, Ziba
    Ghaznavi, Habib
    Khoei, Samideh
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 105 (07) : 2615 - 2624
  • [32] Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology
    Haas, Paige
    Muralidharan, Monita
    Krogan, Nevan J.
    Kaake, Robyn M.
    Huttenhain, Ruth
    JOURNAL OF PROTEOME RESEARCH, 2021, 20 (02) : 1133 - 1152
  • [33] Reducing COVID-19 quarantine with SARS-CoV-2 testing: a simulation study
    Peng, Bo
    Zhou, Wen
    Pettit, Rowland W.
    Yu, Patrick
    Matos, Peter G.
    Greninger, Alexander L.
    McCashin, Julie
    Amos, Christopher, I
    BMJ OPEN, 2021, 11 (07):
  • [34] Study on the virulence evolution of SARS-CoV-2 and the trend of the epidemics of COVID-19
    Wang, Mengyue
    Yi, Jiabiao
    Jiang, Wen
    MATHEMATICAL METHODS IN THE APPLIED SCIENCES, 2022, 45 (11) : 6515 - 6534
  • [35] SARS-COV-2 (COVID-19) ANOSMIA IN PATIENTS WITH OBESITY: A RETROSPECTIVE STUDY
    Sarantis, N.
    Vlachopoulou, M.
    Chatzis, G.
    ATHEROSCLEROSIS, 2021, 331 : E210 - E210
  • [36] SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study
    Giacomelli, Andrea
    Righini, Elena
    Micheli, Valeria
    Pinoli, Pietro
    Bernasconi, Anna
    Rizzo, Alberto
    Oreni, Letizia
    Ridolfo, Anna Lisa
    Antinori, Spinello
    Ceri, Stefano
    Rizzardini, Giuliano
    PLOS ONE, 2023, 18 (04):
  • [37] Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)
    McCullough, Peter A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)
  • [38] Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection
    Fremont-Smith, Maurice
    Gherlone, Nicole
    Smith, Nora
    Tisdall, Philip
    Ricke, Darrell O.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 331 - 335
  • [39] Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic
    Roghayeh Sheervalilou
    Milad Shirvaliloo
    Saman Sargazi
    Sakine Shirvalilou
    Omolbanin Shahraki
    Younes Pilehvar-Soltanahmadi
    Alireza Sarhadi
    Ziba Nazarlou
    Habib Ghaznavi
    Samideh Khoei
    Applied Microbiology and Biotechnology, 2021, 105 : 2615 - 2624
  • [40] RETRACTED: Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19 (Retracted Article)
    Gurung, Arun Bahadur
    Ali, Mohammad Ajmal
    Lee, Joongku
    El-Zaidy, Mohamed
    Aljowaie, Reem M.
    Almutairi, Saeedah M.
    PLOS ONE, 2022, 17 (06):